VC Profile: Jeito Capital in final stretch of biotech fund deployment
At a time when many big-ticket GPs are buying up specialist life science investors, France-based Jeito Capital is focused on staying an independent investor as it gears up to deploy the remaining third of its EUR 534m debut fund, founder Rafaèle Tordjman tells Unquote.
More on GPs
MML Capital sells GP stake to Wafra and Investcorp
Mid-market PE firm's deal comes amid rise of new entrants into the European GP stakes landscape
WestBridge adds two to investment team
Jessica Ledger and Luke Gilbert have joined the UK-based lower mid-market GP as investment executives
Verdane bolsters German presence with partner hire and new Munich office
Former EMH partner Dominik Schwarz joins growth investor’s second German office
Perwyn hires new head of capital formation from Greenhill
Andrew Harrison will join the UK-based sponsor to help manage and grow its capital base
Latest News
Golding aims to raise EUR 350m for next buyout co-investment fund amid ‘unprecedented’ dealflow
Vehicle expects to make its first deals this year, providing additional equity for deals against a tough fundraising backdrop
Permira to acquire majority stake in Gruppo Florence
Existing shareholders including VAM Investments and management of the Italian fashion group will reinvest, while Italmobiliare will exit
Mimir Group ramps up global origination effort with London office and focus on life science carve-outs
Stockholm-based investor is considering divestments, although challenging market remains a barrier
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt